S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Orchard Therapeutics Price Target & Analyst Ratings (NASDAQ:ORTX)

$12.58
+1.05 (+9.11 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$11.50
Now: $12.58
$12.73
50-Day Range
$11.45
MA: $13.64
$16.72
52-Week Range
$8.65
Now: $12.58
$21.64
Volume108,800 shs
Average Volume162,913 shs
Market Capitalization$1.21 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Orchard Therapeutics (NASDAQ:ORTX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Orchard Therapeutics in the last 12 months. Their average twelve-month price target is $25.14, suggesting that the stock has a possible upside of 99.86%. The high price target for ORTX is $31.00 and the low price target for ORTX is $21.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.14$25.14$24.50$24.50
Price Target Upside: 99.86% upside62.21% upside44.12% upside44.12% upside

Orchard Therapeutics (NASDAQ:ORTX) Consensus Price Target History

Orchard Therapeutics (NASDAQ:ORTX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/17/2019GuggenheimInitiated CoverageBuy$31.00Low
9/15/2019CowenInitiated CoverageBuy$27.00Medium
9/5/2019BarclaysInitiated CoverageOverweight$21.00Low
8/29/2019OppenheimerInitiated CoverageOutperform$26.00High
3/22/2019WedbushReiterated RatingOutperform$25.00High
12/17/2018Goldman Sachs GroupUpgradeNeutral ➝ Buy$18.00 ➝ $21.00High
11/26/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$25.00Medium
(Data available from 10/17/2017 forward)
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel